Myeloma Minimal Residual Disease Testing in the United States: Evidence of Improved Standardization

American Journal of Hematology - United States
doi 10.1002/ajh.24540
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Minimal Residual Disease Testing After Stem Cell Transplantation for Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2015English

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2016English

Flow Cytometry in the Diagnosis and Monitoring of Minimal Residual Disease in Multiple Myeloma

Oncogematologiya
OncologyHematology
2017English

Is This the Time to Introduce Minimal Residual Disease in Multiple Myeloma Clinical Practice?

Clinical Cancer Research
Cancer ResearchOncology
2015English

Minimal Residual Disease

Leukemia Supplements
2012English

Minimal Residual Disease

Bone Marrow Transplantation
TransplantationHematology
2001English

Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma

JAMA Oncology
Cancer ResearchOncology
2017English

Serological Normalisation as a Surrogate Marker for Minimal Residual Disease Negativity in Multiple Myeloma

British Journal of Haematology
Hematology
2018English

Minimal Residual Disease Assessment in Multiple Myeloma: Utility and Feasibility in Resource Constraint Settings of India

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy